摘要
2012年9月国家中医药管理局正式委托世界中医药学会联合会组织开展"中医药临床研究伦理审查平台评估"(CAP)。通过对已完成评估的20家医疗卫生机构的伦理审查平台情况进行综合分析,结合当前美国的伦理监管体系,论述我国自主评估品牌CAP的重要特点,"以评促建"和"持续改进"的实践与受益,以及大力推进CAP评估的重要意义。
In September 2012,the ＂Assessment for Ethics Review of Traditional Chinese Medicine（TCM） Research with Human Participants＂（named CAP,Chinese medicine assessment human research protection system） was officially commissioned to the World Federation of Chinese Medicine Societies to organize by the State Ad ministration of TCM.Through the assessment of 20 medical institutions,a comprehensive analysis on ethical re view platform was conducted.Combined with current regulatory system of ethics in the U.S.,this article discussed independent assessment on important CAP features of local brands,the practice and benefit of ＂construction pro motion based on assessment＂ and ＂continuous improvement,＂ as well as the importance of vigorously promote CAP assessment.
出处
《世界科学技术-中医药现代化》
北大核心
2013年第4期708-714,共7页
Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金
国家中医药管理局中医药行业科研专项(201207006):中医药临床研究伦理审查体系与能力建设
负责人:熊宁宁
关键词
临床研究
伦理平台
CAP评估
以评促建
持续改进
Clinical research
ethics platform
CAP assessment
construction promotion based on assessment
continuous improvement
